Team “Treatment of Amyotrophic Lateral Sclerosis: from genetics to zebrafish”
Edor Kabashi joined the ICM in 2011, where is leader of the team “Amyotrophic Lateral Sclerosis: From Genetics to Treatment”. He received a BSc with honors in 2001 and in PhD in 2008 from the McGill University and did postdoctoral work at Centre of Excellence in Neuromics at University of Montreal. He received many awards, including the Brain Star Award of CIHR Institute of Neuroscience in 2009 and 2011.
Edor Kabashi’s team is aiming to identify novel genetic causes in Amyotrophic Lateral Sclerosis (ALS) and to develop experimental models for these genes to study neurodegenerative processes. This approach also allows the team to use these genetic models for multigenic interactions and drug discovery. Our team has developed innovative screening protocols to identify neuroprotective compounds, to understand molecular mechanisms modulated by these compounds and to advance therapy development in neurological diseases. This project aims at accelerating transition from lab bench to bedside by defining therapeutic avenues for neurodegenerative diseases.